Records containing: Neuroendocrine Tumor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-20Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
-
CLINICAL_TRIALS study record update · 2025-12-30Enhancing Brain and Mental Health Through Respiratory Training: Clinical Applications in Cancer and Neurodegenerative Disease Care for Patients and Caregivers (Breathing Study)
-
CLINICAL_TRIALS study record update · 2025-11-13A Registry for Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2025-09-23An Exploratory Study of [68Ga]Ga-Fibroblast Activation Protein Inhibitor 4 ([68Ga]Ga-FAPI-04) in Patients With High-Grade Neuroendocrine Neoplasms
-
CLINICAL_TRIALS study record update · 2025-09-22A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-23"Imaging With 68Ga-DOTA-peptides and Peptide Receptor Radionuclide Therapy With 177Lu-DOTA-peptides of Gastroenteropancreatic Neuroendocrine Tumors: Interest of Intra-arterial Hepatic Infusion in Patients With Dominant Liver Metastases"
-
CLINICAL_TRIALS study record update · 2025-06-19Exploratory Basket Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. CABATEN Study
-
CLINICAL_TRIALS study record update · 2025-06-10A Phase 1, Non-Randomized, Open-Label, Dose Escalation, Single-Center Study to Determine the Safety, Bio-distribution, and Preliminary Effectiveness of AlphaMedix™ in Adult Subjects With SSRT(+) NETs.
-
CLINICAL_TRIALS study record update · 2024-10-16Randomized, Double-Blinded Phase III Study of CABozantinib Versus Placebo IN Patients With Advanced NEuroendocrine Tumors After Progression on Prior Therapy (CABINET)
-
CLINICAL_TRIALS study record update · 2024-10-16Randomized, Double-Blinded Phase III Study of CABozantinib Versus Placebo IN Patients With Advanced NEuroendocrine Tumors After Progression on Prior Therapy (CABINET)
-
CLINICAL_TRIALS study record update · 2024-08-26Oral Protein Supplements Might Improve Nutritional Status and Quality of Life in Elderly Patients After Standard Pancreatic Resection
-
CLINICAL_TRIALS study record update · 2024-05-06Use of Video Consultation in Follow-up Care for Patients With a NeuroEndocrine Tumor: a Feasibility Study (VIDEO-NET Study)
-
CLINICAL_TRIALS study record update · 2024-05-06Towards Optimal Personalized Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor
-
CLINICAL_TRIALS study record update · 2024-05-06Towards Optimal Personalized Diet and Vitamin Supplementation in NET Patients; a Pilot Study
-
CLINICAL_TRIALS study record update · 2024-05-06Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor: a Randomized Pilot Study (Pilot WIN-study).
-
CLINICAL_TRIALS study record update · 2024-05-06Web-based Tailored Information and Support for Patients With a Neuroendocrine Tumor
-
CLINICAL_TRIALS study record update · 2024-04-30Diagnosis of Neuroendocrine Neoplasms and Assessment of Response to Surgery by Means of Measurement of Gene Transcripts in Blood
-
CLINICAL_TRIALS study record update · 2024-03-01A Study of 18F-MFBG Imaging for the Tumor Burden Evaluation or Diagnostic Performance in Pheochromocytoma, Paraganglioma and Neuroblastoma.
-
CLINICAL_TRIALS study record update · 2023-04-18Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)
-
CLINICAL_TRIALS study record update · 2022-05-10A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®18087 in Subjects With Advanced Neuroendocrine and Gastrointestinal Stromal Tumors (DUET-1)
-
CLINICAL_TRIALS study record update · 2021-09-22Comparator Study of 68Ga-DOTATOC PET/CT With Octreoscan + High-resolution, Contrast-enhanced CT for Diagnosis and Staging in Neuroendocrine Tumors and Other Somatostatin Receptor Positive Tumors
-
CLINICAL_TRIALS study record update · 2021-05-21Proprietary Amino Acid-Based Medical Food (Enterade) in Carcinoid Syndrome and Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency
-
CLINICAL_TRIALS study record update · 2020-07-07Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
-
CLINICAL_TRIALS study record update · 2019-12-26A Pilot Study of FOLFOX in Combination With Bevacizumab in Patients With Advanced Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2019-11-18A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors